Friedreich's Ataxia Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
A Clinical Study to Evaluate the Effect of MIN-102 on the Progression of Friedreich's Ataxia in Male and Female Patients
Condition: Friedreich Ataxia Interventions: Drug: MIN-102; Drug: Placebo Sponsor: Minoryx Therapeutics, S.L. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2019 Category: Research Source Type: clinical trials